Bradley Saenger is the founder of Tonix Pharmaceuticals Holding. Latest round: IPO. Based in La Jolla, CA.
Bradley Saenger serves as the Chief Financial Officer at Tonix Pharmaceuticals, a biotechnology company focused on developing therapies for central nervous system disorders, immunology/immuno-oncology, and infectious diseases. He joined the company in May 2014. Before joining Tonix, he worked as a financial consultant for Shire Pharmaceuticals and Stewart Health Care System, and held leadership positions at Vertex Pharmaceuticals and Alere Inc. He also has a background in public accounting with PricewaterhouseCoopers LLP and other firms in South Africa.
Full founder directory · Investor directory · Company funding database · Fundraising library